Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Recombinant vaccines are one of the most important tools in the medical industry today. These vaccines help prevent the spread of many infectious diseases, such as hepatitis B. In recent years, the growth of the market has been driven by a sharp increase in the incidence of infectious diseases, increased regulatory approvals, increased awareness of health care, and continued innovation in drug and vaccine development.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Recombinant Vaccines market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Recombinant Vaccines market. Detailed analysis of key players, along with key growth strategies adopted by Recombinant Vaccines industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Pfizer Inc
Novartis AG
Protein Science Corporation
GlaxoSmithKline Plc
Merck & Co, Inc
Bharat Biotech
Sanofi S A
Green Cross Corporation
Bayer AG
By Type:
Subunit Recombinant Vaccines
Attenuated Recombinant Vaccines
Vector Recombinant Vaccines
By End-User:
Hospitals & clinics
Pediatrics
Adults
Veterinary
Others
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Recombinant Vaccines Market
-
1.3 Market Segment by Type
-
1.3.1 China Recombinant Vaccines Market Size and Growth Rate of Subunit Recombinant Vaccines from 2016 to 2027
-
1.3.2 China Recombinant Vaccines Market Size and Growth Rate of Attenuated Recombinant Vaccines from 2016 to 2027
-
1.3.3 China Recombinant Vaccines Market Size and Growth Rate of Vector Recombinant Vaccines from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Recombinant Vaccines Market Size and Growth Rate of Hospitals & clinics from 2016 to 2027
-
1.4.2 China Recombinant Vaccines Market Size and Growth Rate of Pediatrics from 2016 to 2027
-
1.4.3 China Recombinant Vaccines Market Size and Growth Rate of Adults from 2016 to 2027
-
1.4.4 China Recombinant Vaccines Market Size and Growth Rate of Veterinary from 2016 to 2027
-
1.4.5 China Recombinant Vaccines Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Recombinant Vaccines Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Recombinant Vaccines Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Recombinant Vaccines Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Recombinant Vaccines Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Recombinant Vaccines Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Recombinant Vaccines Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Recombinant Vaccines Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Recombinant Vaccines Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Recombinant Vaccines by Major Types
-
3.4.1 Market Size and Growth Rate of Subunit Recombinant Vaccines
-
3.4.2 Market Size and Growth Rate of Attenuated Recombinant Vaccines
-
3.4.3 Market Size and Growth Rate of Vector Recombinant Vaccines
4 Segmentation of Recombinant Vaccines Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Recombinant Vaccines by Major End-Users
-
4.4.1 Market Size and Growth Rate of Recombinant Vaccines in Hospitals & clinics
-
4.4.2 Market Size and Growth Rate of Recombinant Vaccines in Pediatrics
-
4.4.3 Market Size and Growth Rate of Recombinant Vaccines in Adults
-
4.4.4 Market Size and Growth Rate of Recombinant Vaccines in Veterinary
-
4.4.5 Market Size and Growth Rate of Recombinant Vaccines in Others
5 Market Analysis by Regions
-
5.1 China Recombinant Vaccines Production Analysis by Regions
-
5.2 China Recombinant Vaccines Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Recombinant Vaccines Landscape Analysis
-
6.1 North China Recombinant Vaccines Landscape Analysis by Major Types
-
6.2 North China Recombinant Vaccines Landscape Analysis by Major End-Users
7 Central China Recombinant Vaccines Landscape Analysis
-
7.1 Central China Recombinant Vaccines Landscape Analysis by Major Types
-
7.2 Central China Recombinant Vaccines Landscape Analysis by Major End-Users
8 South China Recombinant Vaccines Landscape Analysis
-
8.1 South China Recombinant Vaccines Landscape Analysis by Major Types
-
8.2 South China Recombinant Vaccines Landscape Analysis by Major End-Users
9 East China Recombinant Vaccines Landscape Analysis
-
9.1 East China Recombinant Vaccines Landscape Analysis by Major Types
-
9.2 East China Recombinant Vaccines Landscape Analysis by Major End-Users
10 Northeast China Recombinant Vaccines Landscape Analysis
-
10.1 Northeast China Recombinant Vaccines Landscape Analysis by Major Types
-
10.2 Northeast China Recombinant Vaccines Landscape Analysis by Major End-Users
11 Southwest China Recombinant Vaccines Landscape Analysis
-
11.1 Southwest China Recombinant Vaccines Landscape Analysis by Major Types
-
11.2 Southwest China Recombinant Vaccines Landscape Analysis by Major End-Users
12 Northwest China Recombinant Vaccines Landscape Analysis
-
12.1 Northwest China Recombinant Vaccines Landscape Analysis by Major Types
-
12.2 Northwest China Recombinant Vaccines Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Pfizer Inc
-
13.1.1 Pfizer Inc Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Novartis AG
-
13.2.1 Novartis AG Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Protein Science Corporation
-
13.3.1 Protein Science Corporation Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 GlaxoSmithKline Plc
-
13.4.1 GlaxoSmithKline Plc Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Merck & Co, Inc
-
13.5.1 Merck & Co, Inc Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Bharat Biotech
-
13.6.1 Bharat Biotech Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Sanofi S A
-
13.7.1 Sanofi S A Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Green Cross Corporation
-
13.8.1 Green Cross Corporation Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 Bayer AG
-
13.9.1 Bayer AG Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Recombinant Vaccines Market Size and Growth Rate of Subunit Recombinant Vaccines from 2016 to 2027
-
Figure China Recombinant Vaccines Market Size and Growth Rate of Attenuated Recombinant Vaccines from 2016 to 2027
-
Figure China Recombinant Vaccines Market Size and Growth Rate of Vector Recombinant Vaccines from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Recombinant Vaccines Market Size and Growth Rate of Hospitals & clinics from 2016 to 2027
-
Figure China Recombinant Vaccines Market Size and Growth Rate of Pediatrics from 2016 to 2027
-
Figure China Recombinant Vaccines Market Size and Growth Rate of Adults from 2016 to 2027
-
Figure China Recombinant Vaccines Market Size and Growth Rate of Veterinary from 2016 to 2027
-
Figure China Recombinant Vaccines Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Recombinant Vaccines Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Recombinant Vaccines Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Recombinant Vaccines Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Recombinant Vaccines Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Recombinant Vaccines Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Recombinant Vaccines Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Recombinant Vaccines Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Recombinant Vaccines Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Recombinant Vaccines
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Recombinant Vaccines by Different Types from 2016 to 2027
-
Table Consumption Share of Recombinant Vaccines by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Subunit Recombinant Vaccines
-
Figure Market Size and Growth Rate of Attenuated Recombinant Vaccines
-
Figure Market Size and Growth Rate of Vector Recombinant Vaccines
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Recombinant Vaccines by Different End-Users from 2016 to 2027
-
Table Consumption Share of Recombinant Vaccines by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospitals & clinics
-
Figure Market Size and Growth Rate of Pediatrics
-
Figure Market Size and Growth Rate of Adults
-
Figure Market Size and Growth Rate of Veterinary
-
Figure Market Size and Growth Rate of Others
-
Table China Recombinant Vaccines Production by Regions
-
Table China Recombinant Vaccines Production Share by Regions
-
Figure China Recombinant Vaccines Production Share by Regions in 2016
-
Figure China Recombinant Vaccines Production Share by Regions in 2021
-
Figure China Recombinant Vaccines Production Share by Regions in 2027
-
Table China Recombinant Vaccines Consumption by Regions
-
Table China Recombinant Vaccines Consumption Share by Regions
-
Figure China Recombinant Vaccines Consumption Share by Regions in 2016
-
Figure China Recombinant Vaccines Consumption Share by Regions in 2021
-
Figure China Recombinant Vaccines Consumption Share by Regions in 2027
-
Table North China Recombinant Vaccines Consumption by Types from 2016 to 2027
-
Table North China Recombinant Vaccines Consumption Share by Types from 2016 to 2027
-
Figure North China Recombinant Vaccines Consumption Share by Types in 2016
-
Figure North China Recombinant Vaccines Consumption Share by Types in 2021
-
Figure North China Recombinant Vaccines Consumption Share by Types in 2027
-
Table North China Recombinant Vaccines Consumption by End-Users from 2016 to 2027
-
Table North China Recombinant Vaccines Consumption Share by End-Users from 2016 to 2027
-
Figure North China Recombinant Vaccines Consumption Share by End-Users in 2016
-
Figure North China Recombinant Vaccines Consumption Share by End-Users in 2021
-
Figure North China Recombinant Vaccines Consumption Share by End-Users in 2027
-
Table Central China Recombinant Vaccines Consumption by Types from 2016 to 2027
-
Table Central China Recombinant Vaccines Consumption Share by Types from 2016 to 2027
-
Figure Central China Recombinant Vaccines Consumption Share by Types in 2016
-
Figure Central China Recombinant Vaccines Consumption Share by Types in 2021
-
Figure Central China Recombinant Vaccines Consumption Share by Types in 2027
-
Table Central China Recombinant Vaccines Consumption by End-Users from 2016 to 2027
-
Table Central China Recombinant Vaccines Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Recombinant Vaccines Consumption Share by End-Users in 2016
-
Figure Central China Recombinant Vaccines Consumption Share by End-Users in 2021
-
Figure Central China Recombinant Vaccines Consumption Share by End-Users in 2027
-
Table South China Recombinant Vaccines Consumption by Types from 2016 to 2027
-
Table South China Recombinant Vaccines Consumption Share by Types from 2016 to 2027
-
Figure South China Recombinant Vaccines Consumption Share by Types in 2016
-
Figure South China Recombinant Vaccines Consumption Share by Types in 2021
-
Figure South China Recombinant Vaccines Consumption Share by Types in 2027
-
Table South China Recombinant Vaccines Consumption by End-Users from 2016 to 2027
-
Table South China Recombinant Vaccines Consumption Share by End-Users from 2016 to 2027
-
Figure South China Recombinant Vaccines Consumption Share by End-Users in 2016
-
Figure South China Recombinant Vaccines Consumption Share by End-Users in 2021
-
Figure South China Recombinant Vaccines Consumption Share by End-Users in 2027
-
Table East China Recombinant Vaccines Consumption by Types from 2016 to 2027
-
Table East China Recombinant Vaccines Consumption Share by Types from 2016 to 2027
-
Figure East China Recombinant Vaccines Consumption Share by Types in 2016
-
Figure East China Recombinant Vaccines Consumption Share by Types in 2021
-
Figure East China Recombinant Vaccines Consumption Share by Types in 2027
-
Table East China Recombinant Vaccines Consumption by End-Users from 2016 to 2027
-
Table East China Recombinant Vaccines Consumption Share by End-Users from 2016 to 2027
-
Figure East China Recombinant Vaccines Consumption Share by End-Users in 2016
-
Figure East China Recombinant Vaccines Consumption Share by End-Users in 2021
-
Figure East China Recombinant Vaccines Consumption Share by End-Users in 2027
-
Table Northeast China Recombinant Vaccines Consumption by Types from 2016 to 2027
-
Table Northeast China Recombinant Vaccines Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Recombinant Vaccines Consumption Share by Types in 2016
-
Figure Northeast China Recombinant Vaccines Consumption Share by Types in 2021
-
Figure Northeast China Recombinant Vaccines Consumption Share by Types in 2027
-
Table Northeast China Recombinant Vaccines Consumption by End-Users from 2016 to 2027
-
Table Northeast China Recombinant Vaccines Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Recombinant Vaccines Consumption Share by End-Users in 2016
-
Figure Northeast China Recombinant Vaccines Consumption Share by End-Users in 2021
-
Figure Northeast China Recombinant Vaccines Consumption Share by End-Users in 2027
-
Table Southwest China Recombinant Vaccines Consumption by Types from 2016 to 2027
-
Table Southwest China Recombinant Vaccines Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Recombinant Vaccines Consumption Share by Types in 2016
-
Figure Southwest China Recombinant Vaccines Consumption Share by Types in 2021
-
Figure Southwest China Recombinant Vaccines Consumption Share by Types in 2027
-
Table Southwest China Recombinant Vaccines Consumption by End-Users from 2016 to 2027
-
Table Southwest China Recombinant Vaccines Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Recombinant Vaccines Consumption Share by End-Users in 2016
-
Figure Southwest China Recombinant Vaccines Consumption Share by End-Users in 2021
-
Figure Southwest China Recombinant Vaccines Consumption Share by End-Users in 2027
-
Table Northwest China Recombinant Vaccines Consumption by Types from 2016 to 2027
-
Table Northwest China Recombinant Vaccines Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Recombinant Vaccines Consumption Share by Types in 2016
-
Figure Northwest China Recombinant Vaccines Consumption Share by Types in 2021
-
Figure Northwest China Recombinant Vaccines Consumption Share by Types in 2027
-
Table Northwest China Recombinant Vaccines Consumption by End-Users from 2016 to 2027
-
Table Northwest China Recombinant Vaccines Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Recombinant Vaccines Consumption Share by End-Users in 2016
-
Figure Northwest China Recombinant Vaccines Consumption Share by End-Users in 2021
-
Figure Northwest China Recombinant Vaccines Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Pfizer Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer Inc
-
Figure Sales and Growth Rate Analysis of Pfizer Inc
-
Figure Revenue and Market Share Analysis of Pfizer Inc
-
Table Product and Service Introduction of Pfizer Inc
-
Table Company Profile and Development Status of Novartis AG
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG
-
Figure Sales and Growth Rate Analysis of Novartis AG
-
Figure Revenue and Market Share Analysis of Novartis AG
-
Table Product and Service Introduction of Novartis AG
-
Table Company Profile and Development Status of Protein Science Corporation
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Protein Science Corporation
-
Figure Sales and Growth Rate Analysis of Protein Science Corporation
-
Figure Revenue and Market Share Analysis of Protein Science Corporation
-
Table Product and Service Introduction of Protein Science Corporation
-
Table Company Profile and Development Status of GlaxoSmithKline Plc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline Plc
-
Figure Sales and Growth Rate Analysis of GlaxoSmithKline Plc
-
Figure Revenue and Market Share Analysis of GlaxoSmithKline Plc
-
Table Product and Service Introduction of GlaxoSmithKline Plc
-
Table Company Profile and Development Status of Merck & Co, Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck & Co, Inc
-
Figure Sales and Growth Rate Analysis of Merck & Co, Inc
-
Figure Revenue and Market Share Analysis of Merck & Co, Inc
-
Table Product and Service Introduction of Merck & Co, Inc
-
Table Company Profile and Development Status of Bharat Biotech
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bharat Biotech
-
Figure Sales and Growth Rate Analysis of Bharat Biotech
-
Figure Revenue and Market Share Analysis of Bharat Biotech
-
Table Product and Service Introduction of Bharat Biotech
-
Table Company Profile and Development Status of Sanofi S A
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi S A
-
Figure Sales and Growth Rate Analysis of Sanofi S A
-
Figure Revenue and Market Share Analysis of Sanofi S A
-
Table Product and Service Introduction of Sanofi S A
-
Table Company Profile and Development Status of Green Cross Corporation
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Green Cross Corporation
-
Figure Sales and Growth Rate Analysis of Green Cross Corporation
-
Figure Revenue and Market Share Analysis of Green Cross Corporation
-
Table Product and Service Introduction of Green Cross Corporation
-
Table Company Profile and Development Status of Bayer AG
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer AG
-
Figure Sales and Growth Rate Analysis of Bayer AG
-
Figure Revenue and Market Share Analysis of Bayer AG
-
Table Product and Service Introduction of Bayer AG
-
